Products
Search Result
Home >

Products >

human gastrointestinal peptides online manufacturer Manufacturer

The search yielded  (9)  results

Human Secretin Peptide Catalog Number KS042012 CAS 108153-74-8

Secretin (human),Catalog Number: KS042012,CAS NO.: 108153-74-8 Secretin (human) is a gastrointestinal peptide that stimulates pancreatic and biliary secretion. Also thought to play a role in the regulation of the hypothalamus-pituitary-adrenal axis.

Uroguanylin (human) Catalog KS041017 CAS 152175-68-3

Gastrin-Releasing Peptide (human),Catalog Number: KS042009,CAS NO.: 93755-85-2 Uroguanylin is a natriuretic peptide, a hormone that regulates sodium excretion by the kidney when excess NaCl is consumed. Uroguanylin and guanylin are related peptides that activate common guanylate cyclase signaling molecules in the intestine and kidney.

DOTA-[Tyr3]-Octreotide Gastrointestinal Peptides Catalog KS042011 CAS 177943-89-4

DOTA-[Tyr3]-Octreotide,Catalog Number: KS042011,CAS NO.: 177943-89-4 Octreotide is a peptide agonist for sst2, sst3 and sst5 somatostatin receptors. IC50/Kd values (nM) at cloned human somatostatin receptors are: 290 - 1140 (sst1), 0.4 - 2.1 (sst2), 4.4 - 34.5 (sst3), > 1000 (sst4), and 5.6 - 32 (sst5).

GIP (human) Catalog KS041003 CAS 100040-31-1

GIP (human),Catalog Number: KS041003,CAS NO.: 100040-31-1 GIP (Glucose-dependent Insulinotropic Polypeptide or also known as Gastric Inhibitory Polypeptide) is a 42-amino acid peptide released by the K cells of the duodenum and jejunum in response to food intake. GIP, together with GLP (Gastric-like Peptide) are members of the hormone peptide family of Incretins which stimulate insulin secretion from pancreatic islet -cells, and also appears to promote beta cell proliferatio

Gastrin 1 (human) Catalog KS042006 CAS 10047-33-3

Gastrin 1 (human),Catalog Number: KS042006,CAS NO.: 10047-33-3 Gastrin-1 is also referred to as Gastrin-17 or Little Gastrin. Secretion of gastrin is induced by food intake and causes the release of gastric acid in the stomach. Secreted by the G cells in the gastric mucosa, it is one of the major bioactive forms of gastrin found in tissue and plasma (the other bioactive form is Gastrin-34 or Big Gastrin). Both Gastrin-17 and Gastrin-34 are carboxy-amidated and partially

GLP-2 (1-34) (human) Diabetes Peptides CAS 99120-49-7 Catalog Number KS032009

GLP-2 (1-34) (human),CAS#: 99120-49-7, Catalog Number: KS032009 Glucagon-like peptide-2 (GLP-2) promotes nutrient absorption via expansion of the mucosal epithelium by stimulation of crypt cell proliferation and inhibition of apoptosis in the small intestine. It also reduces epithelial permeability, and decreases meal-stimulated gastric acid secretion and gastrointestinal motility. GLP-2 promotes the expansion of the intestinal epithelium through stimulation of the GLP-2

Secretin Growth Hormone Secreting Peptides Catalog Number KS042012 CAS 108153-74-8

Secretin (human),Catalog Number: KS042012,CAS NO.: 108153-74-8 Secretin (human) is a gastrointestinal peptide that stimulates pancreatic and biliary secretion. Also thought to play a role in the regulation of the hypothalamus-pituitary-adrenal axis.

Human Calcitonin Related Intermedin KS-V Peptide Catalog Number KS091008 CAS 1188922-20-4

Intermedin (human),Catalog Number: KS091008,CAS NO.: 1188922-20-4 Intermedins are a part of the calcitonin/gene-related peptide (CGRP) family. In vitro experimentation has demonstrated that the synthetic 47 amino acid intermedin peptides act via the calcitonin receptor-like receptor/receptor activity-modifying protein (CRLR/RAMP) complexes by increasing the levels of intracellular cAMP. Unlike calcitonin gene-related peptide (CGRP) and adrenomedullin (ADM), intermedin does

Human GLP-2 Hormone Peptide (1-34) Catalog KS061029 CAS 99120-49-7

GLP-2 (1-34) (human),Catalog Number: KS061029,CAS NO.: 99120-49-7 GLP-2 (Glucagon-like peptide-2) induces the expansion of the mucosal epithelium in the small intestine by stimulating crypt cell proliferation while inhibiting apoptosis. This expansion leads to an increase in nutrient absorption while simultaneously reducing epithelial permeability and decreasing meal-stimulated gastric acid secretion and gastrointestinal motility. GLP-2 achieves these effects by activating

1